forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Market Size, Share, Growth, 2034 GLP-1 trends 2025: real-world data,

1 Its primary purpose is to lower blood sugar, which is determined using the hemoglobin A1C test, which determines average blood sugar levels over a three-month period

It should always be monitored by a healthcare provider

Here is where things stand

safety and efficacy were not different in geriatric adults versus younger adults

GLP-1 RAs, such as semaglutide and tirzepatide, may also help improve metabolic health in patients with PCOS by promoting weight loss, improving insulin sensitivity, and reducing blood glucose levels ( 4 , 6 , 14 )

While semaglutide is generally well tolerated, some people experience mild to moderate side effects such as nausea, vomiting, diarrhea, constipation, or abdominal discomfortsymptoms that often improve as your body adjusts to the medication